All data is delayed
See More

Aspen finalises GSK deal for £164m

Dec 03 2012 08:22


Company Data


Last traded 307
Change 2
% Change 1
Cumulative volume 1903852
Market cap 0

Last Updated: 21-10-2016 at 05:06. Prices are delayed by 15 minutes. Source: McGregor BFA

Related Articles

Aspen boosts profit, Asian unit robust

Aspen buys GSK Aussie drugs for R2.2bn

Aspen unit to buy drug portfolio from GSK

Aspen prepared to help bridge ARV shortages

Aspen buys GSK brands

Aspen: Earning to between rise 18%-24%


Johannesburg - Aspen Pharmacare Holdings [JSE:APN] said on Monday it has finalised the acquisition of medicines from GlaxoSmithKline for £163.8m.

The deal, announced in August, was initially pegged at £172m.



Read Fin24’s Comments Policy publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Company Snapshot

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

Do you use all your downloaded apps on your smartphone?

Previous results · Suggest a vote